Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pivotal phase 3 trial of EscharEx

Trial Profile

Pivotal phase 3 trial of EscharEx

Phase of Trial: Phase III

Latest Information Update: 13 Nov 2018

At a glance

  • Drugs EscharEx (Primary)
  • Indications Leg ulcer; Wounds
  • Focus Registrational; Therapeutic Use
  • Sponsors MediWound
  • Most Recent Events

    • 13 Nov 2018 According to a MediWound media release, this trial is expected to begin in the first half of 2019.
    • 13 Nov 2018 Planned initiation date changed from 1 Jan 2018 to 1 Jan 2019, according to a MediWound media release.
    • 05 Sep 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top